Improving Patient Care at the Bedside.

As part of our on-going exploration into and validation of the practical and purposeful uses of Medication on Demand (MOD®), the worlds-first oral PCA, the Avancen MOD Corporation is pleased to partner with various hospitals in clinical trials. Study Title: A PROSPECTIVE RANDOMIZED TRIAL OF AN ORAL PATIENT CONTROLLED ANALGESIA DEVICE VERSUS USUAL CARE FOR THE DELIVERY OF AS NEEDED ORAL PAIN MEDICATIONS FOLLOWING TOTAL HIP ARTHROPLASTY

This is a restricted area of the avancen.com site and is intended for healthcare professionals who are engaged in clinical research. If you would like more information about this study or would like to discuss using MOD® in a clinical research trial in your facility, please contact us.